{"id":"NCT03845140","sponsor":"Merck KGaA, Darmstadt, Germany","briefTitle":"L-PZQ ODT in Schistosoma Infected Children","officialTitle":"An Open Label, Phase III Efficacy and Safety Study of L-PZQ ODT in Schistosoma Infected Children 3 Months to 6 Years of Age, Including a 2:1 Randomized, Controlled Cohort of Schistosoma Mansoni Infected Children 4 to 6 Years of Age Treated With L PZQ ODT or Commercial PZQ (Biltricide®)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2019-09-02","primaryCompletion":"2021-10-11","completion":"2021-10-11","firstPosted":"2019-02-19","resultsPosted":"2024-03-21","lastUpdate":"2024-03-21"},"enrollment":288,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Schistosomiasis"],"interventions":[{"type":"DRUG","name":"L-PZQ ODT 50 mg/kg","otherNames":[]},{"type":"DRUG","name":"Biltricide®","otherNames":[]},{"type":"DRUG","name":"L-PZQ ODT 60 mg/kg","otherNames":[]}],"arms":[{"label":"Cohort 1a: 4 to 6 years L-PZQ ODT 50 mg/kg","type":"EXPERIMENTAL"},{"label":"Cohort 1b: 4 to 6 years Biltricide® 40 mg/kg","type":"ACTIVE_COMPARATOR"},{"label":"Cohort 2: 2 to 3 years L-PZQ ODT 50 mg/kg","type":"EXPERIMENTAL"},{"label":"Cohort 3: 3 to 24 months L-PZQ ODT 50 mg/kg","type":"EXPERIMENTAL"},{"label":"Cohort 4a: 3 months to 6 years L-PZQ ODT 50 mg/kg","type":"EXPERIMENTAL"},{"label":"Cohort 4b: 3 months to 6 years L-PZQ ODT 60 mg/kg","type":"EXPERIMENTAL"}],"summary":"The study would evaluate the safety and efficacy of L-praziquantel orodispersible (L-PZQ ODT) tablets in Schistosoma infected children aged 3 months to 6 years.","primaryOutcome":{"measure":"Cohort 1a and Cohort 1b: Number of Participants With Clinical Cure Determined by Kato-Katz Method","timeFrame":"at Week 3","effectByArm":[{"arm":"Cohort 1a: 4 to 6 Years L-PZQ ODT 50 mg/kg","deltaMin":86,"sd":null},{"arm":"Cohort 1b: 4 to 6 Years Biltricide® 40 mg/kg","deltaMin":39,"sd":null}],"pValues":[]},"eligibility":{"minAge":"3 Months","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":9},"locations":{"siteCount":2,"countries":["Côte d’Ivoire","Kenya"]},"refs":{"pmids":["36893784"],"seeAlso":["https://clinicaltrials.emdgroup.com/en/trial-details/?id=MS200661_0003","https://www.merckgroup.com/en/company/contact-us/medinfo-contact-map.html"]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":100},"commonTop":["Abdominal pain","Diarrhoea","Somnolence","Vomiting","Upper respiratory tract infection"]}}